Drug intelligence / Profile preview

SMARTT e-Patch

Development stage
Preclinical
Lead developer
Rhenovia Pharma
Modality
Nanoparticles → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems
Administration
Transdermal
01

Overview

The SMARTT e-Patch is an advanced electronic transdermal drug delivery platform developed by Rhenovia Pharma. It is designed as a programmable system capable of controlled, chronobiological administration of up to seven different medicinal products simultaneously. The technology integrates several innovations, including an ultra-slim battery, a flexible printed electronic circuit, and UV-LED ink that interacts with novel photolabile ligands within transdermal nanovectors to trigger drug release. This system allows physicians to program specific dosage schedules remotely, aiming to improve bioavailability and efficacy while minimizing side effects. Although initially developed for central nervous system disorders such as Alzheimer's disease, the platform is intended for a broad range of chronic conditions requiring complex medication regimens.

Brand names
SMARTT e-Patch
Other names
e-Patch

Beyond the preview

Go deeper on SMARTT e-Patch.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMARTT e-Patch.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call